HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].

Abstract
A 77-year-old man was diagnosed as hepatocellular carcinoma, and was referred to our hospital. After he was treated by transcatheter chemoembolization, he underwent a left hepatic lobectomy of the liver and cholecystectomy. Serum AFP and PIVKA-II remarkably elevated 7 months after surgery, and CT scan revealed multiple metastatic nodules in bilateral lungs. The nodules were diagnosed as lung metastasis of HCC. Because the lesions grew larger, S-1/IFN was administered. Diagnostic imaging and tumor markers showed a marked improvement after 4 courses of S-1/IFN therapy, and he is still alive with good condition without recurrence and progression of tumors.
AuthorsYoshiteru Katsura, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Masahiro Tanemura, Koji Umeshita, Kenichi Wakasa, Yuichiro Doki, Masaki Mori, Hiroaki Nagano
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 38 Issue 12 Pg. 2487-9 (Nov 2011) ISSN: 0385-0684 [Print] Japan
PMID22202422 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Interferon-alpha
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy, pathology, therapy)
  • Drug Combinations
  • Embolization, Therapeutic
  • Hepatectomy
  • Humans
  • Interferon-alpha (administration & dosage, therapeutic use)
  • Liver Neoplasms (drug therapy, pathology, therapy)
  • Lung Neoplasms (drug therapy, secondary)
  • Male
  • Oxonic Acid (administration & dosage, therapeutic use)
  • Recurrence
  • Remission Induction
  • Tegafur (administration & dosage, therapeutic use)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: